Yuichi Kitai

996 total citations
45 papers, 747 citations indexed

About

Yuichi Kitai is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Yuichi Kitai has authored 45 papers receiving a total of 747 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Immunology, 14 papers in Oncology and 11 papers in Molecular Biology. Recurrent topics in Yuichi Kitai's work include Immune Cell Function and Interaction (11 papers), T-cell and B-cell Immunology (10 papers) and Cytokine Signaling Pathways and Interactions (8 papers). Yuichi Kitai is often cited by papers focused on Immune Cell Function and Interaction (11 papers), T-cell and B-cell Immunology (10 papers) and Cytokine Signaling Pathways and Interactions (8 papers). Yuichi Kitai collaborates with scholars based in Japan, United States and France. Yuichi Kitai's co-authors include Tadashi Matsuda, Ryuta Muromoto, Taro Kawai, Takumi Kawasaki, Takuya Sueyoshi, Shizuo Akira, Ken J. Ishii, Jian Zou, Kouji Kobiyama and Kenji Oritani and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Yuichi Kitai

41 papers receiving 744 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuichi Kitai Japan 14 387 377 204 175 48 45 747
Yingming Jiang China 13 407 1.1× 353 0.9× 212 1.0× 112 0.6× 25 0.5× 23 810
Antony Symons United States 11 323 0.8× 613 1.6× 154 0.8× 159 0.9× 42 0.9× 16 891
Rachel B. Delston United States 8 572 1.5× 237 0.6× 242 1.2× 142 0.8× 27 0.6× 9 827
Shyamasree Datta United States 14 264 0.7× 367 1.0× 168 0.8× 140 0.8× 18 0.4× 17 664
Yayi Gao China 16 261 0.7× 560 1.5× 156 0.8× 59 0.3× 40 0.8× 19 853
Dimitrios G. Zisoulis United States 13 663 1.7× 482 1.3× 183 0.9× 423 2.4× 17 0.4× 16 1.2k
Marja Kreike Belgium 14 515 1.3× 517 1.4× 184 0.9× 448 2.6× 23 0.5× 19 939
Maaike W.G. Looman Netherlands 20 496 1.3× 486 1.3× 338 1.7× 154 0.9× 21 0.4× 37 1.1k
Anette Sundstedt Sweden 22 242 0.6× 1.0k 2.8× 336 1.6× 136 0.8× 54 1.1× 36 1.3k
Felix Scholz United States 6 430 1.1× 149 0.4× 184 0.9× 106 0.6× 46 1.0× 6 749

Countries citing papers authored by Yuichi Kitai

Since Specialization
Citations

This map shows the geographic impact of Yuichi Kitai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuichi Kitai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuichi Kitai more than expected).

Fields of papers citing papers by Yuichi Kitai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuichi Kitai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuichi Kitai. The network helps show where Yuichi Kitai may publish in the future.

Co-authorship network of co-authors of Yuichi Kitai

This figure shows the co-authorship network connecting the top 25 collaborators of Yuichi Kitai. A scholar is included among the top collaborators of Yuichi Kitai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuichi Kitai. Yuichi Kitai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yamamoto, Kazuki, Ken Takashima, Ryuta Muromoto, et al.. (2025). A selective RPL15 PROTAC degrader enhances anti-PD-1 immunotherapy in a murine melanoma tumor model. Oncogene. 44(50). 4846–4854.
3.
Kitai, Yuichi, et al.. (2024). Potential of targeting signal-transducing adaptor protein-2 in cancer therapeutic applications. SHILAP Revista de lepidopterología. 5(2). 251–259.
4.
Ose, Toyoyuki, Yuichi Kitai, Ryuta Muromoto, et al.. (2023). STAP-2–Derived Peptide Suppresses TCR-Mediated Signals to Initiate Immune Responses. The Journal of Immunology. 211(5). 755–766. 2 indexed citations
5.
Muromoto, Ryuta, et al.. (2022). Regulation of NFKBIZ gene promoter activity by STAT3, C/EBPβ, and STAT1. Biochemical and Biophysical Research Communications. 613. 61–66. 8 indexed citations
6.
Kashiwakura, Jun‐ichi, Yuichi Sekine, Yuichi Kitai, et al.. (2022). STAP-2 Is a Novel Positive Regulator of TCR-Proximal Signals. The Journal of Immunology. 209(1). 57–68. 8 indexed citations
7.
Yamada, Shunsuke, Yuichi Kitai, Takashi Tadokoro, et al.. (2022). Identification of RPL15 60S Ribosomal Protein as a Novel Topotecan Target Protein That Correlates with DAMP Secretion and Antitumor Immune Activation. The Journal of Immunology. 209(1). 171–179. 11 indexed citations
8.
Kitai, Yuichi, Jun‐ichi Kashiwakura, Ryuta Muromoto, et al.. (2021). Positive interactions between STAP-1 and BCR-ABL influence chronic myeloid leukemia cell proliferation and survival. Biochemical and Biophysical Research Communications. 556. 185–191. 8 indexed citations
9.
Kashiwakura, Jun‐ichi, et al.. (2021). Signal-transducing adaptor protein-2 has a nonredundant role for IL-33-triggered mast cell activation. Biochemical and Biophysical Research Communications. 572. 80–85.
10.
Muromoto, Ryuta, Tomohiro Matsumoto, Yuichi Kitai, et al.. (2020). The mechanism of Tyk2 deficiency-induced immunosuppression in mice involves robust IL-10 production in macrophages. Cytokine. 130. 155077–155077. 10 indexed citations
11.
Ichii, Michiko, Kenji Oritani, Hirohiko Shibayama, et al.. (2020). Signal-transducing adapter protein-1 is required for maintenance of leukemic stem cells in CML. Oncogene. 39(34). 5601–5615. 13 indexed citations
12.
Ichii, Michiko, Kenji Oritani, Hideaki Saito, et al.. (2020). Signal-transducing adaptor protein-2 delays recovery of B lineage lymphocytes during hematopoietic stress. Haematologica. 106(2). 424–436. 7 indexed citations
13.
Muromoto, Ryuta, Yuichi Kitai, Jun‐ichi Kashiwakura, et al.. (2019). IκB-ζ Expression Requires Both TYK2/STAT3 Activity and IL-17–Regulated mRNA Stabilization. ImmunoHorizons. 3(5). 172–185. 18 indexed citations
14.
Kitai, Yuichi, Sumihito Togi, Yuichi Sekine, et al.. (2017). STAP-2 protein promotes prostate cancer growth by enhancing epidermal growth factor receptor stabilization. Journal of Biological Chemistry. 292(47). 19392–19399. 24 indexed citations
15.
Muromoto, Ryuta, et al.. (2016). IL-17A plays a central role in the expression of psoriasis signature genes through the induction of IκB-ζ in keratinocytes. International Immunology. 28(9). 443–452. 58 indexed citations
16.
Togi, Sumihito, Ryuta Muromoto, Osamu Ikeda, et al.. (2015). Kaposi's sarcoma-associated herpesvirus-encoded LANA associates with glucocorticoid receptor and enhances its transcriptional activities. Biochemical and Biophysical Research Communications. 463(3). 395–400. 3 indexed citations
17.
Sekine, Yuichi, Sumihito Togi, Ryuta Muromoto, et al.. (2015). STAP-2 Protein Expression in B16F10 Melanoma Cells Positively Regulates Protein Levels of Tyrosinase, Which Determines Organs to Infiltrate in the Body. Journal of Biological Chemistry. 290(28). 17462–17473. 13 indexed citations
18.
Kato, Masaya, Ryuta Muromoto, Sumihito Togi, et al.. (2015). PML suppresses IL-6-induced STAT3 activation by interfering with STAT3 and HDAC3 interaction. Biochemical and Biophysical Research Communications. 461(2). 366–371. 8 indexed citations
19.
Kitai, Yuichi, Osamu Takeuchi, Takumi Kawasaki, et al.. (2014). Negative Regulation of Melanoma Differentiation-associated Gene 5 (MDA5)-dependent Antiviral Innate Immune Responses by Arf-like Protein 5B. Journal of Biological Chemistry. 290(2). 1269–1280. 17 indexed citations
20.
Kitai, Yuichi, et al.. (2011). Cell selective targeting of a simian virus 40 virus-like particle conjugated to epidermal growth factor. Journal of Biotechnology. 155(2). 251–256. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yingming Jiang Breakdown of academic impact, for papers by Antony Symons Breakdown of academic impact, for papers by Rachel B. Delston Breakdown of academic impact, for papers by Shyamasree Datta Breakdown of academic impact, for papers by Yayi Gao Breakdown of academic impact, for papers by Dimitrios G. Zisoulis Breakdown of academic impact, for papers by Marja Kreike Breakdown of academic impact, for papers by Maaike W.G. Looman Breakdown of academic impact, for papers by Anette Sundstedt Breakdown of academic impact, for papers by Felix Scholz
Rankless by CCL
2026